Kestra Investment Management
REGN icon

Kestra Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Kestra Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
+659
New +$449K 0.01% 351
2025
Q2 		– Sell
-1
Closed -$635 – 926
2025
Q1 		$635 Sell
1
-1,259
-100% -$866K ﹤0.01% 850
2024
Q4 		$898K Buy
1,260
+644
+105% +$540K 0.04% 153
2024
Q3 		$648K Buy
616
+200
+48% +$223K 0.03% 169
2024
Q2 		$437K Buy
+416
New +$403K 0.03% 88

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kestra Investment Management's REGN Position: Q2 2026 in Review

Kestra Investment Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 659 shares worth $411K. The stake represents 0.01% of the portfolio and ranks #351 among its holdings. This is a return to the name: Kestra Investment Management previously reported a position in REGN as recently as Q1 2025.

Kestra Investment Management first reported a position in REGN in Q2 2024 and has held it in 5 quarters since. The position peaked at $898K in Q4 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Kestra Investment Management held 659 shares of Regeneron Pharmaceuticals worth $411K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Kestra Investment Management position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #351 holding.
  • Kestra Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Kestra Investment Management's Regeneron Pharmaceuticals position peaked at $898K in Q4 2024.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.